Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 6, Number 2—April 2000

Research

Serologic Response to Culture Filtrate Antigens of Mycobacterium ulcerans during Buruli Ulcer Disease

Karen M. Dobos*†, Ellen A. Spotts*†, Barbara J. Marston*, C. Robert Horsburgh*, and C. Harold King*Comments to Author 
Author affiliations: *Emory University School of Medicine, Atlanta, Georgia, USA; and †Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Main Article

Table 2

Serologic and skin test responses of Buruli ulcer patients and healthy controls from the same villages

Clinical presentation Total Burulin (+)a AB to MUCFb (+)c
Total BU patients (n = 39) 28 (71.8) 26 (66.7)
(%)
Healed (n = 16) 15 (93.8) 11 (68.8)
(%)
Ulcerative (n = 17) 11 (64.7) 11 (64.7)
(%)
Early ulcerative (n = 6) 2 (33.4) 4 (66.7)
(%)
No scar or ulcer (n = 21) 3 (14.3) 7 (33.3)
(%)

aTotal Burulin (+) numbers and (%) are derived from columns one and two of Table 1 added together without regard to PPD status, and thus represent the highest possible number (percentage) of Burulin (+) BU patients.
bMUCF = Mycobacterium ulcerans culture filtrate.
cDenotes all BU patients and controls with any antibodies detected by Western blot analysis against MUCF.

Main Article

TOP